Intubation Conditions: Clinical Trials

5 trials for Intubation Conditions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 41Completed 1

Follow Intubation Conditions: new trials by email Literature Review of Intubation Conditions trials Research Report on Intubation Conditions

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lean Body Weight-adjusted Rocuronium Dose and Intubation Conditions
he patients who are administered rocuronium according to LBW were categorized as "LBW", and The group number for those administer according to TBW was categorized as "K". - Body Weight Changes, Rocuronium
CompletedDUYGU DEMİROZ1802023-01-302023-09-28
Intubating Conditions During Rapid Sequence Induction in Elderly With Either Suxamethonium 1.0 mg/kg or Rocuronium 1.0 mg/kg
Suxamethonium, Rocuronium - Intubation Conditions
Phase 4CompletedMatias Vested1022021-08-122024-03-19
An Observational Study of Cisatracurium 0.15 mg/kg in Young and Elderly (≥ 80 Years) Patients.
Cisatracurium - Onset Time of Cisatracurium, Duration of Action of Cisatracurium
CompletedMatias Vested602021-07-052022-01-26
Rapid Sequence Intubation With Magnesium-rocuronium Compared With Succinylcholine - A Randomised Clinical Study
Magnesium perfusion, Rocuronium, Placebo perfusion - Intubation Conditions
Phase 2CompletedUniversity Hospital, Geneva2802012-09-012015-07-20
Assisted Intubation
Intubation - Intubation Conditions
CompletedMcGill University Health Centre/Research Institute of the McGill University Health Centre122011-03-012013-10-25

Narrower conditions

Body Weight Changes (1)

Broader conditions

Body Weight (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Rocuronium (2)  ·  Succinylcholine (2)  ·  Intubation (1)  ·  Magnesium (1)  ·  Sodium Chloride (1)  ·  bis(p-chlorophenyl)acetic acid (1)  ·  cisatracurium (1)

Sponsors

Matias Vested (2)  ·  DUYGU DEMİROZ (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  University Hospital, Geneva (1)

Countries

Denmark (2)  ·  Canada (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Christian Kern, MD, Prof (1)  ·  Christoph Czarnetzki, MD, PD (1)  ·  Lars S Rasmussen (1)  ·  Thomas Hemmerling, MD (1)

Results publications

PMID 33337797, PMID 36263238, PMID 36344924